These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 18522163

  • 1. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE, Strongin IuS, Talabaev MV, Aleĭnikova OV.
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [Abstract] [Full Text] [Related]

  • 2. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 3. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL.
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [Abstract] [Full Text] [Related]

  • 4. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL.
    Cancer; 2009 Jul 01; 115(13):2956-63. PubMed ID: 19402050
    [Abstract] [Full Text] [Related]

  • 5. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F, Gandola L, Marchianò A, Simonetti F, Poggi G, Adduci A, Clerici CA, Luksch R, Biassoni V, Meazza C, Catania S, Terenziani M, Musumeci R, Fossati-Bellani F, Massimino M.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1011-9. PubMed ID: 17904307
    [Abstract] [Full Text] [Related]

  • 6. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.
    Pediatr Blood Cancer; 2004 Jul 15; 43(1):46-54. PubMed ID: 15170889
    [Abstract] [Full Text] [Related]

  • 7. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A, Pizer B.
    Pediatr Blood Cancer; 2010 Apr 15; 54(4):649-51. PubMed ID: 20146223
    [Abstract] [Full Text] [Related]

  • 8. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.
    Pediatr Blood Cancer; 2007 Apr 15; 48(4):408-15. PubMed ID: 17066462
    [Abstract] [Full Text] [Related]

  • 9. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.
    J Clin Oncol; 2001 May 15; 19(10):2696-704. PubMed ID: 11352962
    [Abstract] [Full Text] [Related]

  • 10. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1031-7. PubMed ID: 16343801
    [Abstract] [Full Text] [Related]

  • 11. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A, Lassaletta A, González-Vicent M, Sevilla J, Díaz MA, Madero L.
    J Neurooncol; 2005 Jan 15; 71(1):33-8. PubMed ID: 15719272
    [Abstract] [Full Text] [Related]

  • 12. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
    Ridola V, Grill J, Doz F, Gentet JC, Frappaz D, Raquin MA, Habrand JL, Sainte-Rose C, Valteau-Couanet D, Kalifa C.
    Cancer; 2007 Jul 01; 110(1):156-63. PubMed ID: 17541945
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ.
    Pediatr Blood Cancer; 2008 May 01; 50(5):970-5. PubMed ID: 17941070
    [Abstract] [Full Text] [Related]

  • 14. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M, Gandola L, Cefalo G, Lasio G, Riva D, Fossati-Bellani F, Gianni MC, Luksch R, Tesoro-Tess JD, Lombardi F.
    Childs Nerv Syst; 2000 Jan 01; 16(1):15-20. PubMed ID: 10672424
    [Abstract] [Full Text] [Related]

  • 15. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, Atlas MP, Gonzalez-Gomez I, Miller D, Finlay JL.
    Pediatr Blood Cancer; 2008 Mar 01; 50(3):715-7. PubMed ID: 17009232
    [Abstract] [Full Text] [Related]

  • 16. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 17. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.
    J Clin Oncol; 2004 Dec 15; 22(24):4881-7. PubMed ID: 15611503
    [Abstract] [Full Text] [Related]

  • 18. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F, Baumert BG, Creak AL, Warrington AP, Ashley S, Traish D, Brada M.
    Pediatr Blood Cancer; 2008 Mar 15; 50(3):554-60. PubMed ID: 17941071
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report.
    Packer RJ, Siegel KR, Sutton LN, Evans AE, D'Angio G, Rorke LB, Bunin GR, Schut L.
    Ann Neurol; 1988 Oct 15; 24(4):503-8. PubMed ID: 3239953
    [Abstract] [Full Text] [Related]

  • 20. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):312-8. PubMed ID: 17668858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.